tradingkey.logo

Evaxion Biotech A/S

EVAX
View Detailed Chart

2.610USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
36.61MMarket Cap
LossP/E TTM

Evaxion Biotech A/S

2.610

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.61%

5 Days

-4.04%

1 Month

+9.21%

6 Months

+8.75%

Year to Date

-38.25%

1 Year

-80.30%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts
BUY
Current Rating
38.000
Target Price
1355.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Evaxion A/S
EVAX
2
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Ionis Pharmaceuticals Inc
IONS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(7)
Neutral(3)
Buy(2)
Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.015
Neutral
RSI(14)
49.551
Neutral
STOCH(KDJ)(9,3,3)
33.289
Sell
ATR(14)
0.204
High Vlolatility
CCI(14)
-67.554
Neutral
Williams %R
75.000
Sell
TRIX(12,20)
0.469
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
2.787
Sell
MA10
2.723
Sell
MA20
2.645
Sell
MA50
2.560
Buy
MA100
2.084
Buy
MA200
4.241
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.
Ticker SymbolEVAX
CompanyEvaxion Biotech A/S
CEO
Websitehttps://evaxion.ai/
KeyAI